Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Epilepsy Behav ; 90: 209-216, 2019 01.
Article in English | MEDLINE | ID: mdl-30581077

ABSTRACT

BACKGROUND: Epilepsy mostly affects children in sub-Saharan Africa. However, little is known about the therapeutic itinerary of these children living with epilepsy (CWE). This study aimed to describe the therapeutic itinerary of CWE in Kinshasa and to analyze its relationships with clinical features, behavioral problems, and cognitive impairment. METHODS: This hospital-based study has included 104 CWE aged 6 to 17  years. The features of their therapeutic itinerary and their relationship with clinical features, behavioral problems, and cognitive impairment were analyzed. RESULTS: The vast majority of CWE (87%) has started their therapeutic itinerary by the Western medicine. The first source of information about epilepsy as well as the type of antiepileptic treatment varied with the socioeconomic status of families of CWE. The total duration of the therapeutic itinerary was shorter for the CWE who were living with both their parents (P = .038), who had generalized seizures (P = .0073) or who had no family history of epileptic seizures (P = .019). The CWE who had total behavioral problem, compared with the others, were putting more time (P = .021) to reach the Centre de Santé Mentale Telema (CSMT) after the suspicion or the diagnostic of epilepsy. The total duration of CWE who had cognitive impairment (P = .021) was longer than that of CWE who had not cognitive impairment. CONCLUSION: The therapeutic itinerary of CWE in Kinshasa began with Western medicine. The remainder of this therapeutic itinerary looks like what is described in sub-Saharan literature with the majority of CWE seeking the healing based on beliefs. This study also shows that the therapeutic itinerary of CWE was associated with socioeconomic conditions, clinical features, behavioral problems, and cognitive impairment.


Subject(s)
Anticonvulsants/therapeutic use , Child Behavior Disorders/drug therapy , Child Behavior Disorders/epidemiology , Cognitive Dysfunction/drug therapy , Cognitive Dysfunction/epidemiology , Epilepsy/drug therapy , Epilepsy/epidemiology , Adolescent , Child , Child Behavior Disorders/psychology , Cognitive Dysfunction/psychology , Cross-Sectional Studies , Democratic Republic of the Congo/epidemiology , Epilepsy/psychology , Female , Humans , Male , Parents/psychology
SELECTION OF CITATIONS
SEARCH DETAIL
...